Higher incidence of relapse in patients with acute myelocytic leukemia infused with higher doses of CD34+ cells from leukapheresis products autografted during the first remission. (2010)

First Author: Gorin NC
Attributed to:  Expansion of the GMP facility for Stem Cell Therapy at Imperial College funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1182/blood-2009-11-252197

PubMed Identifier: 20479285

Publication URI: http://europepmc.org/abstract/MED/20479285

Type: Journal Article/Review

Volume: 116

Parent Publication: Blood

Issue: 17

ISSN: 0006-4971